Research programme: small molecule therapeutics - C&C Research Laboratories
Alternative Names: Immunological disorder and cancer therapeutics - C&C Research LaboratoriesLatest Information Update: 04 Aug 2023
At a glance
- Originator C&C Research Laboratories
- Developer Agency for Science, Technology and Research; C&C Research Laboratories; National Skin Centre
- Class Anti-inflammatories; Antineoplastics; Skin disorder therapies; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer; Immunological disorders; Skin disorders